There is a critical issue surrounding the Medicare Part D program, specifically as it relates to coverage.
All tagged fda
There is a critical issue surrounding the Medicare Part D program, specifically as it relates to coverage.
The North Carolina Department of Health and Human Services is cautioning families about certain infant formula that has been recalled by Abbott for potentially containing a bacteria that can lead to hospitalization in infants. The recall includes powdered formulas Similac, Alimentum, EleCare and EleCare Jr., and they should not be used.
The FDA now authorizes and the Centers for Disease Control and Prevention recommends individuals who received the Moderna COVID-19 vaccine get a booster dose after five months. This announcement from federal agencies comes just three days after the announcement of a shortened wait time for a booster from six months to five months for individuals who received the Pfizer vaccine.
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death
The Centers for Disease Control and Prevention recommends anyone 18 years or older who received the Pfizer or Moderna COVID-19 vaccine get a booster six months after their second dose to help strengthen and extend protections against COVID-19. This comes after the Food and Drug Administration authorized the boosters for such use today.
Governor Roy Cooper and North Carolina Department of Health and Human Services Secretary Mandy K. Cohen, M.D. provided an update on the state’s COVID-19 key metrics and trends.
The N.C. House on Thursday, Aug. 5, concurred with the Senate on a bill giving parents control over the COVID vaccine.
Following a thorough safety review, the Centers for Disease Control and Prevention and the Food and Drug Administration have confidence that the Johnson & Johnson vaccine is safe and effective in preventing COVID-19 and recommend its continued use to prevent serious illness, hospitalization and death from COVID-19.
Out of an abundance of caution, the CDC and FDA announced a recommendation to pause use of the Johnson & Johnson COVID-19 vaccine. Our primary concern is the health and safety of all North Carolinians. Therefore, NCDHHS is following the recommendation of the CDC and FDA and has asked our vaccinating providers to pause the administration of the J&J COVID-19 vaccine until we learn more.
Attorney General Josh Stein today called on the Food and Drug Administration (FDA) to ban menthol cigarettes. A menthol cigarette ban would benefit public health, decrease youth smoking, and help mitigate harm to communities of color.